Evaluation of Buprenorphine Extended-Release Subcutaneous Injection at Alternative Injection Locations
Clinical trial NCT05704543 · COMPLETED
Trial details
- NCT number
- NCT05704543
- Sponsor
- Indivior Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-01
- Primary completion
- 2023-11-01
- Enrollment
- 132
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.